Price target upside
Kalaris Therapeutics, Inc. Price Target: +358.7% vs Current Price
KLRS target gap is +358.7% from $4.08 to $18.71. As of 2026-08-14.
Direct answer
Kalaris Therapeutics, Inc.'s analyst target implies +358.7%.
The average target is $18.71 compared with a recorded current price of $4.08.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 14, 2026.
Get free Kalaris Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.08
- Average price target
- $18.71
- High price target
- $25.00
- Low price target
- $7.00
- Low target gap
- +71.6%
- Target upside
- +358.7%
- High target gap
- +512.7%
- Target range width
- 441.2%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- August 14, 2026
- Valid through
- August 21, 2026